CLYM CIK: 1768446

Climb Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−35.7
FY22:
−45.1
FY23:
−40.3
FY24:
−82.0
FY25:
−67.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−35.5
FY22:
−43.7
FY23:
−40.8
FY24:
–
FY25:
−67.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−47.5
FY22:
−45.2
FY23:
−35.1
FY24:
–
FY25:
−59.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−47.5
FY22:
−45.2
FY23:
−35.1
FY24:
−73.9
FY25:
−59.9

All amounts in millions USD Data sources:SEC EDGARTwelve Data